Cargando…
Fungal Infection : Diagnosis and Management.
Fungal Infection: Diagnosis and Management, 4th Edition is a concise and up-to-date guide to the clinical manifestations, laboratory diagnosis and management of superficial, subcutaneous and systemic fungal infections. This highly acclaimed book has been extensively revised and updated throughout to...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Hoboken :
John Wiley & Sons,
2011.
|
| Edición: | 4th ed. |
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Fungal Infection : DIAGNOSIS AND MANAGEMENT; Contents; Preface to the fourth edition; Preface to the first edition; Acknowledgements; 1 Introduction; 1.1 The nature of fungi; 1.2 Classification and nomenclature of fungi and fungal diseases; 1.3 Fungi as human pathogens; 1.3.1 The superficial mycoses; 1.3.2 The subcutaneous mycoses; 1.3.3 The systemic mycoses; 1.4 The changing pattern of fungal infection; 1.5 New directions in diagnosis; 1.6 New directions in treatment and prevention; Further reading; 2 Laboratory diagnosis of fungal infection; 2.1 Introduction; 2.2 Collection of specimens.
- 2.2.1 Skin, nails and hair2.2.2 Mucous membranes; 2.2.3 Ear; 2.2.4 Eye; 2.2.5 Blood; 2.2.6 Cerebrospinal fluid; 2.2.7 Urine; 2.2.8 Other fluids; 2.2.9 Lower respiratory tract specimens; 2.2.10 Pus; 2.2.11 Bone marrow; 2.2.12 Tissue; 2.2.13 Medical devices; 2.3 Specimens for serological tests; 2.4 Specimens for antifungal drug level determinations; 2.5 Transport of specimens; 2.6 Interpretation of laboratory test results; 2.6.1 Direct microscopic examination; 2.6.2 Histopathological examination; 2.6.3 Immunohistochemistry; 2.6.4 In situ hybridization; 2.6.5 Culture; 2.6.6 Fungal identification.
- 2.6.7 Molecular identification2.6.8 Serological tests; 2.6.9 ß-D-glucan detection; 2.7 Molecular diagnosis of fungal infection; Further reading; 3 Antifungal drugs; 3.1 Introduction; 3.2 Allylamines; 3.2.1 Mechanism of action; 3.3 Terbinafine; 3.3.1 Spectrum of activity; 3.3.2 Acquired resistance; 3.3.3 Pharmacokinetics; 3.3.4 Pharmaceutics; 3.3.5 Therapeutic use; 3.3.6 Mode of administration; 3.3.7 Drug interactions; 3.3.8 Toxicity and adverse reactions; 3.4 Other allylamine compounds for topical administration; 3.4.1 Naftifine; 3.5 Azoles; 3.5.1 Mechanism of action.
- 3.5.2 Acquired resistance3.5.3 Drug interactions; 3.6 Fluconazole; 3.6.1 Spectrum of activity; 3.6.2 Acquired resistance; 3.6.3 Pharmacokinetics; 3.6.4 Pharmaceutics; 3.6.5 Therapeutic use; 3.6.6 Mode of administration; 3.6.7 Drug interactions; 3.6.8 Toxicity and adverse reactions; 3.7 Itraconazole; 3.7.1 Spectrum of activity; 3.7.2 Acquired resistance; 3.7.3 Pharmacokinetics; 3.7.4 Pharmaceutics; 3.7.5 Therapeutic use; 3.7.6 Mode of administration; 3.7.7 Drug interactions; 3.7.8 Toxicity and adverse reactions; 3.8 Ketoconazole; 3.8.1 Spectrum of activity; 3.8.2 Acquired resistance.
- 3.8.3 Pharmacokinetics3.8.4 Pharmaceutics; 3.8.5 Therapeutic use; 3.8.6 Mode of administration; 3.8.7 Drug interactions; 3.8.8 Toxicity and adverse reactions; 3.9 Posaconazole; 3.9.1 Spectrum of activity; 3.9.2 Acquired resistance; 3.9.3 Pharmacokinetics; 3.9.4 Pharmaceutics; 3.9.5 Therapeutic use; 3.9.6 Mode of administration; 3.9.7 Drug interactions; 3.9.8 Toxicity and adverse reactions; 3.10 Voriconazole; 3.10.1 Spectrum of activity; 3.10.2 Acquired resistance; 3.10.3 Pharmacokinetics; 3.10.4 Pharmaceutics; 3.10.5 Therapeutic use; 3.10.6 Mode of administration; 3.10.7 Drug interactions.